If you need help accessing our website, call 855-698-9991
Skip to main content
NYU Langone Provider

Andre L. Moreira, MD

NYU Langone Provider
  • Specialties: Anatomic Pathology, Cytopathology
  • Treats: Adults
  • Language: English
  • Phone: 212-263-5470
View Locations

Positions
Board Certifications
  • American Board of Pathology - Anatomic Pathology, 2001
  • American Board of Pathology (Cytopathology), 2001
Education and Training
  • Fellowship, NYU Medical Center, Cytopathology, 2001
  • Residency, NYU Medical Center, Anatomic Pathology, 2000

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
     
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Agewell
     
    • Agewell
  • Amidacare
     
    • Amidacare
  • Cigna
     
    • Cigna EPO/POS
    • Cigna PPO
  • ElderPlan
     
    • ElderPlan
  • Emblem
     
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
     
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
  • Fidelis
     
    • Fidelis Child Health
    • Fidelis Exchange
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
     
    • GHI CBP
    • GHI HMO
  • HIP
     
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP EPO/PPO
    • HIP HMO
    • HIP Medicaid
    • HIP Medicare
    • HIP POS
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Andre L. Moreira, MD does not accept insurance.

Locations and Appointments

NYU Pathology Associates

550 1st Avenue, Suite TH461, New York, NY 10016

View Map
Phone

212-263-5470

Fax

212-263-5509

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

  • A PHASE II OPEN-LABEL MULTICENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF NEOADJUVANT AND ADJUVANT TIRAGOLUMAB PLUS ATEZOLIZUMAB WITH OR WITHOUT PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED RESECTABLE STAGE II IIIA OR SELECT IIIB NON-SMALL CELL LUNG CANCER

    Learn More

  • MULTICENTER PHASE II NEOADJUVANT AND ADJUVANT STUDY OF ALECTINIB ENTRECTINIB OR VEMURAFENIB PLUS COBIMETINIB IN PATIENTS WITH STAGES I-III NON-SMALL CELL LUNG CANCER WITH ALK ROS1 NTRK OR BRAF V600E MOLECULAR ALTERATIONS

    Learn More
View All Research Studies (2)

Read All Publications (261)

Related News

Genetic Change Drives Some Lung Cancers
Read Story
NYU Langone’s Biobank Boosts Medical Research & Patient Care
Read Story